Latest Astrocyte Stories

In a study just published in STEM CELLS Translational Medicine, researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer. Durham, NC (PRWEB) May 16, 2013 Researchers have found a new way to increase the survival of stem...

Norwegian University of Science and Technology Scientists can see which cells communicate with each other in the brain, by flipping a neural light switch There are cells in your brain that recognize very specific places, and have that as one of their main jobs. These cells, called place cells, are found in an area behind your temple called the hippocampus. While these cells must be sent information from nearby cells to do their job, so far no one has been able to determine exactly what...

New research published in The Journal of Neuroscience suggests that modifying signals sent by astrocytes, our star-shaped brain cells, may help to limit the spread of damage after an ischemic brain stroke. The study in mice, by neuroscientists at Tufts University School of Medicine, determined that astrocytes play a critical role in the spread of damage following stroke. The National Heart Foundation reports that ischemic strokes account for 87% of strokes in the United States. Ischemic...

WATCH VIDEO: [Forebrain Engraftment In Mice] redOrbit Staff & Wire Reports - Your Universe Online A group of non-neural cells found in the human central nervous system may be more essential to the complexity of our brains than previously believed, according to new research published in Thursday’s edition of the journal Cell Stem Cell. A team led by Steven A. Goldman and Maiken Nedergaard of the University of Rochester Medical Center’s (URMC) Center for Translational...

New framework for brain communications offers insight into brain disease, says TAU researcher The transistors and wires that power our electronic devices need to be mounted on a base material known as a "motherboard." Our human brain is not so different — neurons, the cells that transmit electrical and chemical signals, are connected to one another through synapses, similar to transistors and wires, and they need a base material too. But the cells serving that function in the brain...

SUNNYVALE, Calif., Feb. 28, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced that Dr. John W. Commissiong, Chief Scientific Officer, will be presenting data generated in six hydroxydopamine (6-OHDA) rodent models of Parkinson's disease at the 15(th) Annual Meeting...

SUNNYVALE, Calif. and ALACHUA, Fla., Feb. 25, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced that the companies will be making a joint poster presentation March 6-7, 2013...

WASHINGTON, Feb. 4, 2013 /PRNewswire-USNewswire/ -- A study published in The Proceedings of the National Academy of Sciences USA has revealed that the disease process in amyotrophic lateral sclerosis (ALS) involves a complex genetic interplay between motor neurons and astrocytes. Motor neurons are the cells that die during the disease, leading to paralysis. Astrocytes normally support motor neurons but switch to the opposite role during disease progression. ALS is a progressive...

SUNNYVALE, Calif., Feb. 4, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today reported that upon further analysis of the data reported on January 9th, 2013, the striatal reinnervation (densitometry) data produced in the 6 hydroxydopamine (6-OHDA) neurorestoration rat model of...

SUNNYVALE, Calif., Jan. 28, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced the launch of the Company's new website at www.amarantus.com. "2012 was an exceptionally productive year for Amarantus with the acquisition of two diagnostic platforms to expand...